IPO registrations (S-1, F-1) · Registrants
CVRx, Inc.
- SEC CIK
- 1235912 · filings on EDGAR ↗
- Former names
- CVRX INC (2003–2013)
- Registration
- Form S-1, first filed 2021-06-04, last 2021-06-23; 1 initial registration, 1 amendment
- Outcome
- Final prospectus filed 2021-07-01; declared effective 2021-06-29
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 9201 WEST BROADWAY AVENUE, SUITE 650, Minneapolis, MN 55445
- Ticker
- CVRX (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- CVRx, Inc. on the corporate pages
Offering terms
- Proposed price range
- $15.00–$17.00 per share (S-1/A filed 2021-06-23)
- Final price
- $3.73 per share, below the range (424B4 filed 2021-07-01, an initial public offering)
- Shares sold
- 7,000,000
- Gross proceeds
- $26,110,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CVRX
- Lead underwriters
- J.P. Morgan (3,010,000 shares); Piper Sandler (1,750,000 shares); William Blair (1,400,000 shares)
- Syndicate
- Canaccord Genuity (840,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: CVRx, Inc. Fuzzy (name and state)
- Business registration: CVRx, Inc. Fuzzy (name and state)
- Business registration: CVRx, Inc. Fuzzy (name and state)
- Business registration: CVRx, Inc. Fuzzy (name and state)
- Business registration: CVRX, INC. Fuzzy (name and state)
- Business registration: CVRX, INC. Fuzzy (name and state)
- Business registration: CVRX, INC. Fuzzy (name and state)
- Business registration: CVRX, INC. Fuzzy (name and state)
- Business registration: CVRX, INC. Fuzzy (name and state)
- Federal award recipient: CVRX INC Fuzzy (name and state)
- Form D issuer: CVRx, Inc. EXACT (CIK (EXACT))
- SEC filer: CVRx, Inc. EXACT (CIK (EXACT))
- Person page: Michael D Dale Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-06-04 | S-1 | S-1 (registration) | CVRx, Inc. | 0001104659-21-077026 ↗ |
| 2021-06-23 | S-1/A | S-1/A (amendment) | CVRx, Inc. | 0001104659-21-084344 ↗ |
| 2021-06-29 | S-1MEF | S-1MEF (added securities) | CVRx, Inc. | 0001104659-21-087028 ↗ |
| 2021-06-29 | EFFECT | EFFECT (declared effective) | CVRx, Inc. | 9999999995-21-002577 ↗ |
| 2021-07-01 | 424B4 | 424B4 (final prospectus) | CVRx, Inc. | 0001104659-21-088225 ↗ |
| 2022-11-15 | EFFECT | EFFECT (declared effective) | CVRx, Inc. | 9999999995-22-003306 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-06-23 | S-1/A | registration statement | $15.00–$17.00 | 6,250,000 | - | Nasdaq CVRX | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2021-07-01 | 424B4 | final prospectus | $3.73 | 7,000,000 | $26,110,000 | Nasdaq CVRX | 4 | primary document; price line, shares headline, proceeds computed, underwriting table 4, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Behbahani Ali | Director | 7 | 2021–2024 | ||
| BRINTNALL JOHN | Officer | Chief Strategy Officer and Sec; CHIEF STRATEGY OFFICER AND SEC | 5 | 2021–2022 | |
| BRUHN-DING DEAN | Officer | VP of Reg. Affairs and QA; VP OF REG. AFFAIRS AND QA | 6 | 2021–2022 | |
| Galle Liz | Officer | VP of Global Clinical Research; VP OF GLOBAL CLINICAL RESEARCH | 6 | 2021–2023 | |
| Jain Mudit K. | Director | 15 | 2021–2026 | ||
| JOHNSON & JOHNSON | TenPercentOwner | 8 | 2021–2026 | ||
| Johnson & Johnson Innovation - JJDC, Inc. | TenPercentOwner | 12 | 2021–2026 | ||
| NEA PARTNERS 10 L P | TenPercentOwner | 2 | 2021 | ||
| NEHRA JOHN M | Director | 4 | 2021–2022 | ||
| NEW ENTERPRISE ASSOCIATES 10 L P | TenPercentOwner | 2 | 2021 | ||
| Nielsen Kirk G. | Director | 17 | 2021–2026 | ||
| OASHEIM JARED | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 10 | 2021–2026 | |
| Pardo Geoffrey B | Director | 3 | 2021 | ||
| SANDELL SCOTT D | TenPercentOwner | 2 | 2021 | ||
| SLATTERY JOSEPH P | Director | 15 | 2021–2026 | ||
| VERRASTRO PAUL | Officer | Chief Marketing Officer; CHIEF MKTG & STRAT OFFICER | 14 | 2021–2026 | |
| Yared Nadim | Director,Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER | 12 | 2021–2024 | |
| GLAXOSMITHKLINE PLC | TenPercentOwner | 2 | 2021 | ||
| SHADAN MARTHA | Director | 8 | 2021–2026 | ||
| Palmer Craig E. | Officer | SVP, U.S. Sales; SVP, U.S. SALES | 6 | 2022–2024 | |
| Hykes Kevin | Director; Director,Officer | PRES & CEO | 9 | 2022–2026 | |
| John Robert Allen | Officer | Chief Revenue Officer | 4 | 2024–2026 | |
| Ballinger Kevin J. | Director | 4 | 2024–2026 | ||
| Hill, Mitch C. | Director | 4 | 2024–2026 | ||
| Adamson Philip B. | Officer | Chief Medical Officer | 3 | 2025–2026 | |
| Binkowski Brent | Officer | CHIEF OPERATING OFFICER | 5 | 2025–2026 | |
| Morrison Gregory | Officer | CHIEF HUMAN RESOURCES OFFICER | 2 | 2026 | |
| DALE MICHAEL D | Director | 2 | 2026 | person page Fuzzy |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2020-07-08 | CVRx, Inc. | Other Health Care | $50,000,000 | $50,000,000 | 21 | 1 |
| 2016-06-14 | CVRx, Inc. | Other Health Care | $93,000,000 | $75,350,000 | 20 | 4 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | CVRx, Inc. | MN | Form D private offerings | CIK (EXACT) |
| SEC filer | CVRx, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | CVRx, Inc. | State business registries | name and state | |
| Business registration | CVRx, Inc. | State business registries | name and state | |
| Business registration | CVRx, Inc. | State business registries | name and state | |
| Business registration | CVRx, Inc. | State business registries | name and state | |
| Business registration | CVRX, INC. | State business registries | name and state | |
| Business registration | CVRX, INC. | State business registries | name and state | |
| Business registration | CVRX, INC. | State business registries | name and state | |
| Business registration | CVRX, INC. | State business registries | name and state | |
| Business registration | CVRX, INC. | State business registries | name and state | |
| Federal award recipient | CVRX INC | Federal spending (USAspending) | name and state | |
| Person page | Michael D Dale | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, MN first:
- TACTILE SYSTEMS TECHNOLOGY INC MN
- CABG MEDICAL INC MN
- Cardiovascular Systems Inc MN
- ProUroCare Medical Inc. MN
- CSI MINNESOTA, INC. MN
- ev3 Inc. MN
- TRANSOMA MEDICAL INC MN
- ENTELLUS MEDICAL INC MN
- SANUWAVE Health, Inc. MN
- Kips Bay Medical, Inc. MN
In other datasets, the same topic (Technology) in MN:
- Form D issuer: 313 Software, LLC (Form D private offerings)
- Lobbying client: ACA INTERNATIONAL (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology